Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 10, Pages 321-328
http://dx.doi.org/10.1100/tsw.2010.32
Research Article

Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study

1Stanford Center for Neuroscience in Women's Health, Stanford University School of Medicine, Stanford, CA, USA
2Mood Disorders Program, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA

Received 11 December 2009; Revised 29 January 2010; Accepted 19 February 2010

Academic Editor: Rudy Tanzi

Copyright © 2010 Natalie L. Rasgon et al.

Citations to this Article [53 citations]

The following is the list of published articles that have cited the current article.

  • Borja García-Bueno, Beatriz G. Pérez-Nievas, and Juan C. Leza, “Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?,” The International Journal of Neuropsychopharmacology, vol. 13, no. 10, pp. 1411–1429, 2010. View at Publisher · View at Google Scholar
  • Amanda T. White, and Anne N. Murphy, “Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review,” Journal Of Neurochemistry, vol. 115, no. 4, pp. 845–853, 2010. View at Publisher · View at Google Scholar
  • Chiara Piubelli, Susanne Gruber, Aram El Khoury, Aleksander A. Mathe, Enrico Domenici, and Lucia Carboni, “Nortriptyline influences protein pathways involved in carbohydrate metabolism and actin-related processes in a rat gene-environment model of depression,” European Neuropsychopharmacology, vol. 21, no. 7, pp. 545–562, 2011. View at Publisher · View at Google Scholar
  • Elisa Brietzke, Flávio Kapczinski, Rodrigo Grassi-Oliveira, Iria Grande, Eduard Vieta, and Roger S McIntyre, “Insulin dysfunction and allostatic load in bipolar disorder,” Expert Review of Neurotherapeutics, vol. 11, no. 7, pp. 1017–1028, 2011. View at Publisher · View at Google Scholar
  • Katharine F. Hunt, Yee Seun Cheah, and Stephanie A. Amielpp. 139–164, 2011. View at Publisher · View at Google Scholar
  • Eva Gunde, Ryan Blagdon, and Tomas Hajek, “White matter hyperintensities – from medical comorbidities to bipolar disorders and back,” Annals of Medicine, vol. 43, no. 8, pp. 571–580, 2011. View at Publisher · View at Google Scholar
  • Marisa S Toups, and Madhukar H Trivedi, “Role of metabolic dysfunction in treatment resistance of major depressive disorder,” Neuropsychiatry, vol. 1, no. 5, pp. 441–455, 2011. View at Publisher · View at Google Scholar
  • Mohammad Salehi Sadaghiani, Mehrak Javadi-Paydar, Mohammad Hadi Gharedaghi, Yashar Yousefzadeh Fard, and Ahmad Reza Dehpour, “Antidepressant-like effect of pioglitazone in the forced swimming test in mice: The role of PPAR-gamma receptor and nitric oxide pathway,” Behavioural Brain Research, vol. 224, no. 2, pp. 336–343, 2011. View at Publisher · View at Google Scholar
  • Jennifer S Mason, Heather A Kenna, and Natalie L Rasgon, “Insulin resistance in major depressive disorder and the effects of psychotropic medications,” Clinical Practice, vol. 9, no. 5, pp. 579–589, 2012. View at Publisher · View at Google Scholar
  • Brandon H. Cline, Harry W.M. Steinbusch, Dmitry Malin, Alexander V. Revishchin, Galia V. Pavlova, Raymond Cespuglio, and Tatyana Strekalova, “The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: Possible role of insulin-like growth factor 2,” BMC Neuroscience, vol. 13, no. 1, 2012. View at Publisher · View at Google Scholar
  • Jianwei Wang, Xianglu Rong, Wenlong Li, Yifan Yang, Johji Yamahara, and Yuhao Li, “Rhodiola crenulata root ameliorates derangements of glucose and lipid metabolism in a rat model of the metabolic syndrome and type 2 diabetes,” Journal of Ethnopharmacology, vol. 142, no. 3, pp. 782–788, 2012. View at Publisher · View at Google Scholar
  • Khatereh Sepanjnia, Amirhossein Modabbernia, Mandana Ashrafi, Mohammad-Jafar Modabbernia, and Shahin Akhondzadeh, “Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial,” Neuropsychopharmacology, vol. 37, no. 9, pp. 2093–2100, 2012. View at Publisher · View at Google Scholar
  • Josiane Budni, Kelly R. Lobato, Ricardo W. Binfare, Andiara E. Freitas, Ana Paula Costa, Maria Dolores Martin-de-Saavedra, Rodrigo B. Leal, Manuela G. Lopez, and Ana Lucia S. Rodrigues, “Involvement of PI3K, GSK-3 beta and PPAR gamma in the antidepressant-like effect of folic acid in the forced swimming test in mice,” Journal Of Psychopharmacology, vol. 26, no. 5, pp. 714–723, 2012. View at Publisher · View at Google Scholar
  • Ajaykumar N. Sharma, Khalid M. Elased, and James B. Lucot, “Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice,” Journal Of Psychopharmacology, vol. 26, no. 5, pp. 724–732, 2012. View at Publisher · View at Google Scholar
  • David E. Kemp, and Jinbo Fan, “Cardiometabolic Health in Bipolar Disorder,” Psychiatric Annals, vol. 42, no. 5, pp. 179–183, 2012. View at Publisher · View at Google Scholar
  • David E. Kemp, Faramarz Ismail-Beigi, Stephen J. Ganocy, Carla Conroy, Keming Gao, Sarah Obral, Elizabeth Fein, Robert L. Findling, and Joseph R. Calabrese, “Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity,” Journal of Affective Disorders, vol. 136, no. 3, pp. 1164–1173, 2012. View at Publisher · View at Google Scholar
  • Harald Murck, “Ketamine, magnesium and major depression – From pharmacology to pathophysiology and back,” Journal of Psychiatric Research, vol. 47, no. 7, pp. 955–965, 2013. View at Publisher · View at Google Scholar
  • Vitor Hugo Pereira, João José Cerqueira, Joana Almeida Palha, and Nuno Sousa, “Stressed brain, diseased heart: A review on the pathophysiologic mechanisms of neurocardiology,” International Journal of Cardiology, vol. 166, no. 1, pp. 30–37, 2013. View at Publisher · View at Google Scholar
  • Ladan Kashani, Targol Omidvar, Behnoud Farazmand, Amirhossein Modabbernia, Fatemeh Ramzanzadeh, Ensiyeh Shahrokh Tehraninejad, Mandana Ashrafi, Mina Tabrizi, and Shahin Akhondzadeh, “Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression,” Psychoneuroendocrinology, vol. 38, no. 6, pp. 767–776, 2013. View at Publisher · View at Google Scholar
  • Pierre Thomas, Benjamin Rolland, Olivier Cottencin, Regis Bordet, Julie Deguil, and Renaud Jardri, “Therapeutic Prospects of PPARs in Psychiatric Disorders: A Comprehensive Review,” Current Drug Targets, vol. 14, no. 7, pp. 724–732, 2013. View at Publisher · View at Google Scholar
  • Cynthia V. Calkin, David M. Gardner, Thomas Ransom, and Martin Alda, “The relationship between bipolar disorder and type 2 diabetes: More than just co-morbid disorders,” Annals of Medicine, vol. 45, no. 2, pp. 171–181, 2013. View at Publisher · View at Google Scholar
  • M. Salviati, G. Valeriani, S. Terlizzi, A. Maurizi, C. Melcore, G. F. Romano, R. Panico, and M. Biondi, “The bidirectional relationship between insulin resistance and psychiatric disorders: considerations for using HOMA-IR index,” Clinica Terapeutica, vol. 164, no. 6, pp. E549–E561, 2013. View at Publisher · View at Google Scholar
  • Natalyia Markova, Anton Chernopiatko, Careen A. Schroeter, Dmitry Malin, Aslan Kubatiev, Sergey Bachurin, Joao Costa-Nunes, Harry M. W. Steinbusch, and Tatyana Strekalova, “Hippocampal Gene Expression of Deiodinases 2 and 3 and Effects of 3,5-Diiodo-L-Thyronine T2 in Mouse Depression Paradigms,” Biomed Research International, 2013. View at Publisher · View at Google Scholar
  • Man K. Chan, Michael G. Gottschalk, Frieder Haenisch, Jakub Tomasik, Tillmann Ruland, Hassan Rahmoune, Paul C. Guest, and Sabine Bahn, “Applications of blood-based protein biomarker strategies in the study of psychiatric disorders,” Progress in Neurobiology, 2014. View at Publisher · View at Google Scholar
  • Zhiyou Cai, Ming Xiao, Liying Chang, and Liang-Jun Yan, “Role of insulin resistance in Alzheimer’s disease,” Metabolic Brain Disease, 2014. View at Publisher · View at Google Scholar
  • Y Cheng, R M Rodriguiz, S R K Murthy, V Senatorov, E Thouennon, N X Cawley, D K Aryal, S Ahn, B Lecka-Czernik, W C Wetsel, and Y P Loh, “Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone,” Molecular Psychiatry, 2014. View at Publisher · View at Google Scholar
  • Hamidreza Roohafza, Pedram Shokouh, Masoumeh Sadeghi, Zahra Alikhassy, and Nizal Sarrafzadegan, “A Possible Role for Pioglitazone in the Management of Depressive Symptoms in Metabolic Syndrome Patients (EPICAMP Study): A Double Blind, Randomized Clinical Trial,” International Scholarly Research Notices, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Erwan Thouennon, Yong Cheng, Vida Falahatian, Niamh X. Cawley, and Yoke Peng Loh, “Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection,” Journal of Neurochemistry, 2015. View at Publisher · View at Google Scholar
  • Brandon H. Cline, Joao P. Costa-Nunes, Raymond Cespuglio, Natalyia Markova, Ana I. Santos, Yury V. Bukhman, Aslan Kubatiev, Harry W. M. Steinbusch, Klaus-Peter Lesch, and Tatyana Strekalova, “Dicholine succinate, the neuronal insulin sensitizer, normalizes behavior, REM sleep, hippocampal pGSK3 beta and mRNAs of NMDA receptor subunits in mouse models of depression,” Frontiers in Behavioral Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Sita Sharan Patel, Vineet Mehta, Harish Changotra, and Udayabanu Malairaman, “Depression mediates impaired glucose tolerance and cognitive dysfunction: A neuromodulatory role of rosiglitazone,” Hormones and Behavior, 2015. View at Publisher · View at Google Scholar
  • Kathleen Watson Lin, Tonita E. Wroolie, Thalia Robakis, and Natalie L. Rasgon, “Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Lirong Jiang, Ling Yao, Yifan Yang, Dazhi Ke, Robert Batey, Jianwei Wang, and Yuhao Li, “Jiangzhi Capsule improves fructose-induced insulin resistance in rats: association with repair of the impaired sarcolemmal glucose transporter-4 recycling,” Journal of Ethnopharmacology, 2016. View at Publisher · View at Google Scholar
  • Chao-Wei Huang, Tzu-Wen Hong, Ying-Jing Wang, Ko-Chien Chen, Ju-Chun Pei, Tai-Yuan Chuang, Wen-Sung Lai, Sheng-Hong Tsai, Richard Chu, Wei-Cheng Chen, Lee-Yan Sheen, Satoru Takahashi, Shih-Torng Ding, and Tang-Long Shen, “Ophiocordyceps formosana improves hyperglycemia and depression-like behavior in an STZ-induced diabetic mouse model,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • McIntyre, Cha, Vahtra, Ahmed, Kudlow, Mansur, and Carvalho, “Repurposing of anti-diabetic agents for the treatment of cognitive impairment and mood disorders,” Current Molecular Medicine, vol. 16, no. 5, pp. 465–473, 2016. View at Publisher · View at Google Scholar
  • Christos V. Rizos, Anastazia Kei, and Moses S. Elisaf, “The current role of thiazolidinediones in diabetes management,” Archives of Toxicology, 2016. View at Publisher · View at Google Scholar
  • C Kan, N L Pedersen, K Christensen, S R Bornstein, J Licinio, J H MacCabe, K Ismail, and F Rijsdijk, “Genetic overlap between type 2 diabetes and depression in Swedish and Danish twin registries,” Molecular Psychiatry, 2016. View at Publisher · View at Google Scholar
  • Tatyana Strekalova, João P. Costa-Nunes, Ekaterina Veniaminova, Aslan Kubatiev, Klaus-Peter Lesch, Vladimir P. Chekhonin, Matthew C. Evans, and Harry W.M. Steinbusch, “Insulin receptor sensitizer, dicholine succinate, prevents both Toll-like receptor 4 (TLR4) upregulation and affective changes induced by a high-cholesterol diet in mice,” Journal of Affective Disorders, 2016. View at Publisher · View at Google Scholar
  • N Rasgon, K W Lin, J Lin, E Epel, and E Blackburn, “Telomere length as a predictor of response to Pioglitazone in patients with unremitted depression: a preliminary study,” Translational Psychiatry, vol. 6, no. 1, pp. e709, 2016. View at Publisher · View at Google Scholar
  • Zhan Zhao, Ling Zhang, Xu-Dong Guo, Lu-Lu Cao, Teng-Fei Xue, Xiao-Jie Zhao, Dan-Dan Yang, Jin Yang, Juan Ji, Ji-Ye Huang, and Xiu-Lan Sun, “Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic Apoptosis,” Frontiers in Molecular Neuroscience, vol. 10, 2017. View at Publisher · View at Google Scholar
  • Marco Pistis, and Anna Lisa Muntoni, “Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases,” Endocannabinoids and Lipid Mediators in Brain Functions, pp. 319–346, 2017. View at Publisher · View at Google Scholar
  • Ana SayuriYamagata, Elisa Brietzke, Joshua D. Rosenblat, Ron Kakar, and Roger S. McIntyre, “Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems,” Journal of Affective Disorders, vol. 211, pp. 99–106, 2017. View at Publisher · View at Google Scholar
  • De Larminat, Hardy, Verstuyft, Colle, Rotenberg, Hozer, Fève, and Corruble, “PPAR-γ Agonists for the Treatment of Major Depression: A Review,” Pharmacopsychiatry, vol. 50, no. 2, pp. 49–55, 2017. View at Publisher · View at Google Scholar
  • Romain Colle, Delphine De Larminat, Patrick Hardy, Bruno Fève, Emmanuelle Corruble, Samuel Rotenberg, Franz Hozer, and Céline Verstuyft, “Pioglitazone could induce remission in major depression: A meta-analysis,” Neuropsychiatric Disease and Treatment, vol. 13, pp. 9–16, 2017. View at Publisher · View at Google Scholar
  • Marco Pistis, and Saoirse E. O'Sullivan, “The Role of Nuclear Hormone Receptors in Cannabinoid Function,” 2017. View at Publisher · View at Google Scholar
  • Thanh Thanh L. Nguyen, Lily C. Chan, Kristin Borreginne, Rajas P. Kale, Chunling Hu, and Susannah J. Tye, “A review of brain insulin signaling in mood disorders: From biomarker to clinical target,” Neuroscience & Biobehavioral Reviews, vol. 92, pp. 7–15, 2018. View at Publisher · View at Google Scholar
  • Calum D. Moulton, Christopher W.P. Hopkins, Khalida Ismail, and Daniel Stahl, “Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials,” Psychoneuroendocrinology, vol. 94, pp. 91–103, 2018. View at Publisher · View at Google Scholar
  • Eleni A. Greenwood, Lauri A. Pasch, Marcelle I. Cedars, Richard S. Legro, Esther Eisenberg, and Heather G. Huddleston, “Insulin resistance is associated with depression risk in polycystic ovary syndrome,” Fertility and Sterility, 2018. View at Publisher · View at Google Scholar
  • Jian Zong, Xingzhi Liao, Bingxu Ren, and Zhiping Wang, “The antidepressant effects of rosiglitazone on rats with depression induced by neuropathic pain,” Life Sciences, 2018. View at Publisher · View at Google Scholar
  • Owen R Phillips, Alexander K Onopa, Yevgeniya V Zaiko, and Manpreet K Singh, “Insulin resistance is associated with smaller brain volumes in a preliminary study of depressed and obese children,” Pediatric Diabetes, 2018. View at Publisher · View at Google Scholar
  • Igor Pomytkin, João P. Costa-Nunes, Vladimir Kasatkin, Ekaterina Veniaminova, Anna Demchenko, Alexey Lyundup, Klaus-Peter Lesch, Eugene D. Ponomarev, and Tatyana Strekalova, “Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment,” CNS Neuroscience & Therapeutics, 2018. View at Publisher · View at Google Scholar
  • Manpreet K. Singh, Sara M. Leslie, Mary Melissa Packer, Yevgeniya V. Zaiko, Owen R. Phillips, Elizabeth F. Weisman, Danielle M. Wall, Booil Jo, and Natalie Rasgon, “Brain and behavioral correlates of insulin resistance in youth with depression and obesity,” Hormones and Behavior, 2018. View at Publisher · View at Google Scholar
  • Milos Mitic, Ester Francija, Jelena Radulovic, Miroslav Adzic, Zeljka Brkic, Milica J. Jovicic, and Nadja P. Maric, “Therapeutic strategies for treatment of inflammation-related depression,” Current Neuropharmacology, vol. 16, no. 2, pp. 176–209, 2018. View at Publisher · View at Google Scholar
  • Andrew A. Nierenberg, Sharmin A. Ghaznavi, Isadora Sande Mathias, Kristen K. Ellard, Jessica A. Janos, and Louisa G. Sylvia, “Peroxisome Proliferator Activated Receptor Gamma Co-activator-1 Alpha as a Novel Target for Bipolar Disorder and other Neuropsychiatric Disorders,” Biological Psychiatry, 2018. View at Publisher · View at Google Scholar